Ebglyss Injection, Solution
Product Images NDC 0002-7797

View Photos of Packaging, Regulatory Labels, and Product Appearance

Product Visual Gallery

This gallery contains 28 technical images submitted to the FDA as part of the official labeling for Ebglyss (NDC 0002-7797). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Eli Lilly And Company, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Figure (Ebglyss Ai Ifu 1 V1)

FDA Label Image

Figure (Ebglyss Ai Ifu 2 V1)

Figure (Ebglyss Ai Ifu 2 V1)
This text provides information about a medical device or product with purple injection button, lockring, needle end, lock or unlock symbols, clear base, and gray base cap. The text seems to describe components of a medical syringe or needle.*
FDA Label Image

Figure (Ebglyss Ai Ifu 3 V1)

FDA Label Image

Figure (Ebglyss Ai Ifu 4 V1)

FDA Label Image

Figure (Ebglyss Ai Ifu 5 V1)

FDA Label Image

Figure (Ebglyss Ai Ifu 6 V1)

FDA Label Image

Figure (Ebglyss Ai Ifu 7 V1)

FDA Label Image

Figure (Ebglyss Ai Ifu 8 V1)

FDA Label Image

Figure (Ebglyss Ai Ifu 9 V1)

FDA Label Image

Figure (Ebglyss Ai Lock)

FDA Label Image

Figure (Ebglyss Ai Unlock)

FDA Label Image

Figure (Ebglyss Ifu Inj Sites 1 V1)

FDA Label Image

Figure (Ebglyss Ifu Inj Sites 2 V1)

FDA Label Image

Carton Image Placeholder (Ebglyss Pen Carton 084 00)

FDA Label Image

Carton Image Placeholder (Ebglyss Pfs Carton 9996 02)

Carton Image Placeholder (Ebglyss Pfs Carton 9996 02)
This is a description of a medication named Ebglys (tebrikizumab-lbkz) available in a single-dose prefilled syringe for subcutaneous injection. The dosage provided is 250 mg/2 mL (125 mg/mL). The pharmacy label shows instructions for use.*
FDA Label Image

Figure (Ebglyss Pfs Ifu 1 V1)

FDA Label Image

Figure (Ebglyss Pfs Ifu 10 V1)

FDA Label Image

Figure (Ebglyss Pfs Ifu 2 V1)

Figure (Ebglyss Pfs Ifu 2 V1)
This text provides a description of the parts of a syringe that should be checked before use. It includes information on the plunger rod, finger grips, syringe label and expiration date, viewing window, syringe body, and needle cap. Additionally, it mentions the needle after removing the needle cap.*
FDA Label Image

Figure (Ebglyss Pfs Ifu 3 V1)

Figure (Ebglyss Pfs Ifu 3 V1)
This is a list of medical supplies: Plunger Rod, Used Syringe with Label & Expiration Date, Used Needle, Activated Needle Shield.*
FDA Label Image

Figure (Ebglyss Pfs Ifu 4 V1)

FDA Label Image

Figure (Ebglyss Pfs Ifu 5 V1)

Figure (Ebglyss Pfs Ifu 5 V1)
This description indicates that the item being discussed has a viewing window, likely for monitoring content or information. It also mentions a label with an expiration date, which could be useful for tracking the item's validity or shelf life.*
FDA Label Image

Figure (Ebglyss Pfs Ifu 6 V1)

FDA Label Image

Figure (Ebglyss Pfs Ifu 7 V1)

FDA Label Image

Figure (Ebglyss Pfs Ifu 8 V1)

FDA Label Image

Figure (Ebglyss Pfs Ifu 9 V1)

FDA Label Image

Figure 1 (Ebglyss Uspi 1 V1)

Figure 1 (Ebglyss Uspi 1 V1)
This is a tabulated data showing the proportion of subjects in two studies: ADvocate 1 and ADvocate 2, comparing the use of EBGLYSS 250mg Q2W versus Placebo. In ADvocate 1, there were 283 subjects in the EBGLYSS group and 141 subjects in the Placebo group. In ADvocate 2, there were 281 subjects in the EBGLYSS group and 146 subjects in the Placebo group. The data is presented as a percentage table.*
FDA Label Image

Figure 2 (Ebglyss Uspi 2 V1)

Figure 2 (Ebglyss Uspi 2 V1)
This text provides information on the proportion of subjects participating in "ADvocate 1" and "ADvocate 2" studies, comparing the use of EBGLYSS 250mg Q2W to a placebo. The data includes the number of subjects in each group and the percentage for each treatment group.*
FDA Label Image

Figure (Qr V1)

* These product label images have been analyzed using experimental machine learning. Please verify findings with the primary label text.